Clinical Trials Logo

Clinical Trial Summary

This is a randomized, double-blind, multicentral clinical trial to investigate the efficacy of Recombinant Human Tumor Necrosis Factor-α Receptor Ⅱ IgG Fc fusion protein injection (Yisaipu®) in the treatment of peripheral enthesitis in active axial spondyloarthritis(SpA) patients.


Clinical Trial Description

Mardird sonographic enthesis index (MASEI) was one of the most wide used scoring systems for peripheral enthesitis and the only one based on OMERACT definition of enthesopathy by EULAR. The primary purpose is to assess the MASEI to discover the value of US in diagnosis and prognosis. The second prupose is to assess different maintaining treatment programme in SpA patients with improvement of MASEI. The trial will include 96 patients with stable NSAIDs therapy, and at the first stage they will receive 24-week full-dose of Yisaipu®. Then at the second stage the patients who achieve low disease activity (LDA, ASDAS<2.1) at 24th week will be randomizedly divided into three group: full-dose of Yisaipu® group, half-dose of Yisaipu® group and placebo group. And the blind stage will last for 24 weeks. Patients who complete the 48-week therapy or achieve disease-flare criteria during the blind stage would finish the study. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02960035
Study type Interventional
Source Sun Yat-sen University
Contact
Status Completed
Phase Phase 4
Start date April 2014
Completion date October 2018

See also
  Status Clinical Trial Phase
Recruiting NCT03459274 - Feasibility of an Immersive Virtual Reality Based Biofeedback Intervention for Outpatients in Rheumatology
Completed NCT06252064 - Rehabilitative Therapy and Pridinol in Patients With Lumbar Spondylarthrosis and Chronic Low Back Pain N/A
Active, not recruiting NCT02948608 - Clinical Characteristics of Importance to Outcome in Patients With Spondyloarthritis
Completed NCT03064815 - The SpACE Study - Small Bowel Crohn's Disease and Spondyloarthropathies N/A
Completed NCT00383617 - Referral Recommendations for Axial Spondyloarthritis N/A
Completed NCT04673825 - Monitoring Spondyloarthritis With SpA-Net N/A
Completed NCT01718951 - Golimumab Versus Pamidronate for the Treatment of Axial Spondyloarthropathy: a 48-week Trial Phase 4
Completed NCT03287596 - Cartography and Quantitative Characterization of Achilles Tendon Fibrocartilage by TE = 0ms Imaging at 3T MRI N/A
Recruiting NCT05431283 - Real-world Effectiveness of Tofacitinib on Ulcerative Colitis Associated Spondyloarthropathy